Amisulpride decreases tau protein hyperphosphorylation in the brain of OXYS rats

CONCLUSION: Thus, we propose amisulpride to have therapeutic potential against AD and that it can be the most effective in the early stages of the disease. We found that chronic administration of amisulpride could reduce pathological tau hyperphosphorylation while reducing anxiety.PMID:37641989 | DOI:10.2174/1567205020666230828144651

Source: Current Alzheimer Research - August 29, 2023 Category: Neurology Authors: Camilla A Molobekova Elena M Kondaurova Tatiana V Ilchibaeva Alexander Ya Rodnyy Natalia A Stefanova Nataliya G Kolosova Vladimir S Naumenko Source Type: research